Daniel Adams is an accomplished healthcare executive and multi-location pharmacy owner based in New Zealand. With extensive hands-on experience in community pharmacy operations and healthcare retail management, Daniel has dedicated his career to expanding access to essential health services and driving patient-centered clinical care across his pharmacies.

Dr. Sabrina Braham is a Stanford pediatrician and health innovator focused on improving child health through high value care and technology-enabled care models. She is a 2022-23 Stanford Biodesign Faculty Fellow and a current Design, Innovation and Clinical Entrepreneurship Fellow in Stanford’s Clinical Exellence Research Center.

Dr. Cross is a Surgical Oncologist specializing in the diagnosis and treatment of medical and surgical diseases of the breast. He is Board-certified by the American Board of Surgery and is now head of the Surgical Oncology Breast Division at Highlands Oncology Group In Northwest Arkansas.

Dr. Fred Dirbas is an internationally acclaimed surgeon and pioneer in the field of breast cancer who has been practicing medicine for over thirty years. In his twenty five years at Stanford, Dr. Dirbas has established a robust clinical practice and has affected the lives of countless patients.

Dr. Bob Geng is an Associate Clinical Professor of Medicine and Pediatrics at the University of California, San Diego School of Medicine. He is also affiliated with Rady Children’s Hospital.

Dana Gordon, Pharm. D. is a longtime resident of the Monterey Peninsula of California where he has owned and operated Central Avenue Pharmacy (CAPRx, Inc) since 1991 as President and CEO.

Dr. Arthur Hill is a Cardiothoracic Surgeon and Surgical Director of the Cardiac ICU at UCSF. His interests in patient care include general thoracic, adult cardiac surgery, and thoracic trauma surgery.

Krizia Jurczyk is an Industrial Hygienist in Los Angeles, CA and works for a US government healthcare system. She received her MS in Environmental Policy and Management focused on Health and Safety. She has experience in industrial hygiene consulting and specializes in various environmental instrumentations used for air quality, noise, VOCs, and more.

Dr. Arman Kalamkarian chose internal medicine as his specialty because of his passion for preventative medicine. His mission as a provider in the community is to help keep patients healthy and prevent complications from preventable disease.

Cary Kaufman is a Clinical Professor of Surgery at the University of Washington and the Medical Director of the Bellingham Regional Breast Center. He trained at UCLA School of Medicine and the University of Washington Departments of Surgery.

Dr. David I. Kaufman is a leading Breast Cancer Surgeon in the New York area. He is Board Certified by the American Board of Surgery, a Fellow of the American College of Surgeons, a member of the American Society of Breast Surgeons, the Medical Society of the State of New York and the Nassau County Medical Society.

Diana Laurent, PharmD is a UCSF trained clinical pharmacist with over 30 years of experience in
pharmacy ownership, compounding, preventative medicine and patient care. Her passion is helping
educate patients on how not to need medicine.

Dr. Brian Lyn, Pharm.D. is a University of Southern California trained clinical pharmacist with over 20 years of experience in medication therapy management, travel medicine, compounding, hospital & community patient care. He completed his residency at VA Long Beach and is currently the CEO of a Compounding Pharmacy and Travel Clinic in Newport Beach, California.

Dr. Keith Matheny is a Vanderbilt-trained Otolaryngologist in North Dallas, emphasizing Rhinology & Sleep in adults and children. He has a passion for the business aspects of Otolaryngology, as well as new technology, pharmacotherapy & procedures in ENT.

Jeffrey S. Rosenbloom, MD is a native Texan, born and raised in Dallas and began his San Antonio medical practice in 1999. Dr. Rosenbloom graduated from the University of Texas at Austin and obtained his medical degree from University of Texas Southwestern School of Medicine.

Dr. Jaclyn Tolentino, is a board-certified Family Physician and Integrative & Functional Medicine practitioner at Parsley Health who lives in Los Angeles, California. She graduated from the Edward via Virginia College of Osteopathic Medicine and completed family medicine residency in Miami, FL.

Dr. Wells is a seasoned sleep medicine physician and professional mindset coach specializing in effective and personalized treatment for sleep apnea and insomnia. She is the founder of Super Sleep MD, an online platform for education, support, and promotion of healthy sleep as an essential component of good health and self-care.

Andy is an executive mentor, career adviser and consultant with more than 35 years’ experience in banking and wealth management. He has extensive experience in global financial and capital markets, risk management, governance and executive leadership. With a career spanning London, New York, Sydney, Auckland and Queenstown his major roles include Head of Wealth at Westpac New Zealand, GM - Europe & America at Westpac, Treasurer at Lloyds Bank, Australia and CEO of NZAM.

A leading authority on consumer brand strategy and digital commerce, David Bell is Professor Emeritus at the Wharton School and a Stanford-trained economist. As an early backer of Warby Parker, Harry’s, Bonobos, and Jet, he translated DTC success into foundational principles that founders still build on today. His rigorous, data-driven lens shapes how new consumer categories are defined and captured.

Executive R&D and Business Development professional with a range of start-up to public company experience in the MedTech industry. Skilled in Medical Devices, Management, Capital Equipment, U.S. Food and Drug Administration (FDA), international regulatory, compliance, and clinical affairs, and Research and Development (R&D) functional oversight. He is typically the lead executive responsible for identifying targets, conducting due diligence, and, most importantly, managing the post-merger integration of technology and R&D teams.